Systematic Review: Sweet Syndrome Associated with Inflammatory Bowel Disease.
Sweet syndrome
azathioprine
extraintestinal manifestation
inflammatory bowel disease
skin
Journal
Journal of Crohn's & colitis
ISSN: 1876-4479
Titre abrégé: J Crohns Colitis
Pays: England
ID NLM: 101318676
Informations de publication
Date de publication:
08 Nov 2021
08 Nov 2021
Historique:
pubmed:
24
4
2021
medline:
27
1
2022
entrez:
23
4
2021
Statut:
ppublish
Résumé
Sweet syndrome [SS] is a dermatological condition associated with both inflammatory bowel disease [IBD] and azathioprine use. We performed a systematic review to better delineate clinical characteristics and outcomes of SS in IBD patients. Peer-reviewed, full-text journal publications from inception to April 2020 in English language and adult subjects with IBD were included. Skin biopsy was required as SS gold-standard diagnosis. Azathioprine-associated SS required recent azathioprine introduction or recurrence of SS after azathioprine re-challenge. We included 89 publications with 95 patients [mean age of SS diagnosis: 44 years; 59% female; 20 with azathioprine-associated SS and 75 without]. SS was diagnosed prior to IBD in 5.3%, at time of IBD diagnosis in 29.5% and after diagnosis in 64.2%. In total, 91% of patients with SS had known colonic involvement and the majority [76%] had active IBD at diagnosis; 22% had additional extra-intestinal manifestations. Successful therapies for SS included corticosteroids [90.5%], anti-tumour necrosis factor [TNF]-α inhibitor therapy [14.8%] and azathioprine [11.6%]. Azathioprine-associated SS was distinct, with 85% male patients, mean age of SS diagnosis of 50 years and a lower likelihood to be prescribed corticosteroids for treatment [75% vs 94.7% of non-azathioprine-associated SS, p = 0.008]. All patients with azathioprine-associated SS improved with medication cessation and developed recurrence after re-challenge. SS may precede or occur with IBD diagnosis in almost one-third of cases. Azathioprine and IBD-associated SS present and behave distinctly, especially with regard to gender, age at diagnosis and recurrence risk. Corticosteroids and TNF-α inhibitors have demonstrated efficacy in treating SS in IBD.
Sections du résumé
BACKGROUND AND AIMS
OBJECTIVE
Sweet syndrome [SS] is a dermatological condition associated with both inflammatory bowel disease [IBD] and azathioprine use. We performed a systematic review to better delineate clinical characteristics and outcomes of SS in IBD patients.
METHODS
METHODS
Peer-reviewed, full-text journal publications from inception to April 2020 in English language and adult subjects with IBD were included. Skin biopsy was required as SS gold-standard diagnosis. Azathioprine-associated SS required recent azathioprine introduction or recurrence of SS after azathioprine re-challenge.
RESULTS
RESULTS
We included 89 publications with 95 patients [mean age of SS diagnosis: 44 years; 59% female; 20 with azathioprine-associated SS and 75 without]. SS was diagnosed prior to IBD in 5.3%, at time of IBD diagnosis in 29.5% and after diagnosis in 64.2%. In total, 91% of patients with SS had known colonic involvement and the majority [76%] had active IBD at diagnosis; 22% had additional extra-intestinal manifestations. Successful therapies for SS included corticosteroids [90.5%], anti-tumour necrosis factor [TNF]-α inhibitor therapy [14.8%] and azathioprine [11.6%]. Azathioprine-associated SS was distinct, with 85% male patients, mean age of SS diagnosis of 50 years and a lower likelihood to be prescribed corticosteroids for treatment [75% vs 94.7% of non-azathioprine-associated SS, p = 0.008]. All patients with azathioprine-associated SS improved with medication cessation and developed recurrence after re-challenge.
CONCLUSIONS
CONCLUSIONS
SS may precede or occur with IBD diagnosis in almost one-third of cases. Azathioprine and IBD-associated SS present and behave distinctly, especially with regard to gender, age at diagnosis and recurrence risk. Corticosteroids and TNF-α inhibitors have demonstrated efficacy in treating SS in IBD.
Identifiants
pubmed: 33891004
pii: 6247949
doi: 10.1093/ecco-jcc/jjab079
pmc: PMC8675328
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1864-1876Subventions
Organisme : NIDDK NIH HHS
ID : K08 DK110415
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK123233
Pays : United States
Organisme : NIH HHS
ID : NIDDK K08DK110415
Pays : United States
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Références
Can J Gastroenterol. 2008 Mar;22(3):296-8
pubmed: 18354759
Yale J Biol Med. 2001 May-Jun;74(3):165-8
pubmed: 11501712
Br J Dermatol. 1999 Mar;140(3):565-6
pubmed: 10233302
J Hand Surg Br. 1996 Dec;21(6):792-4
pubmed: 8982930
Acta Derm Venereol. 2008;88(6):601-6
pubmed: 19002347
J Am Acad Dermatol. 2013 Oct;69(4):557-64
pubmed: 23891394
J Rheumatol. 1994 Sep;21(9):1766-8
pubmed: 7799365
Inflamm Bowel Dis. 2007 Dec;13(12):1583-4
pubmed: 17636566
Am J Dermatopathol. 1989 Apr;11(2):99-111
pubmed: 2653084
BMJ Case Rep. 2013 Aug 16;2013:
pubmed: 23955987
Tunis Med. 2012 Mar;90(3):252-7
pubmed: 22481199
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Gastroenterology. 2017 Jan;152(1):29-30
pubmed: 27889378
Acta Derm Venereol. 1991;71(4):360-3
pubmed: 1681661
Medicine (Baltimore). 1976 Sep;55(5):401-12
pubmed: 957999
Am J Dermatopathol. 2007 Apr;29(2):125-33
pubmed: 17414432
Int J Dermatol. 2010 Nov;49(11):1244-9
pubmed: 21038541
Medicine (Baltimore). 2016 Apr;95(15):e3033
pubmed: 27082547
Dermatology. 1993;187(4):303-5
pubmed: 8274797
Am J Gastroenterol. 2007 Dec;102(12):2865-6
pubmed: 18042124
Cutis. 1986 Mar;37(3):167-74
pubmed: 3514153
J Med Case Rep. 2008 Jun 28;2:221
pubmed: 18588703
Acta Derm Venereol. 1989;69(1):52-8
pubmed: 2563609
Am J Gastroenterol. 2017 Sep;112(9):1363
pubmed: 28874857
J Coll Physicians Surg Pak. 2015 Jul;25(7):525-7
pubmed: 26208558
Gut. 2009 Jan;58(1):67, 125
pubmed: 19091830
Clin Exp Dermatol. 2016 Oct;41(7):741-6
pubmed: 27663147
J Am Acad Dermatol. 2013 Oct;69(4):e199-200
pubmed: 24034402
J Am Acad Dermatol. 1997 Mar;36(3 Pt 1):436-9
pubmed: 9091476
Br J Dermatol. 1975 Apr;92(4):363-73
pubmed: 1156550
J Am Acad Dermatol. 2011 Jul;65(1):184-91
pubmed: 21496951
Digestion. 2007;75(2-3):142-3
pubmed: 17671383
Digestion. 2005;72(2-3):195-200
pubmed: 16179788
Acta Derm Venereol. 1985;65(1):77-80
pubmed: 2578713
Int J Dermatol. 1994 Jun;33(6):425-32
pubmed: 8056477
Int J Dermatol. 2016 Sep;55(9):1033-9
pubmed: 26967709
J Infect. 2006 May;52(5):e155-7
pubmed: 16213026
SAGE Open Med Case Rep. 2019 Jun 04;7:2050313X19850968
pubmed: 31210935
Br J Dermatol. 1964 Aug-Sep;76:349-56
pubmed: 14201182
J Cutan Med Surg. 2017 May/Jun;21(3):211-216
pubmed: 28300447
GE Port J Gastroenterol. 2020 Feb;27(2):138-140
pubmed: 32266314
Mayo Clin Proc. 1995 Mar;70(3):234-40
pubmed: 7861810
J Invest Dermatol. 1997 May;108(5):763-8
pubmed: 9129230
J Clin Epidemiol. 2017 Sep;89:218-235
pubmed: 28529185
World J Gastroenterol. 2003 Oct;9(10):2300-7
pubmed: 14562397
Hautarzt. 1990 Oct;41(10):549-56
pubmed: 2258298
Am J Gastroenterol. 2011 Jan;106(1):110-9
pubmed: 20808297
Clin Gastroenterol Hepatol. 2011 May;9(5):e43-4
pubmed: 21145418
J Am Acad Dermatol. 1996 May;34(5 Pt 2):918-23
pubmed: 8621829
Mayo Clin Proc. 2008 Sep;83(9):1026-30
pubmed: 18775203
BMJ Case Rep. 2016 Jan 20;2016:
pubmed: 26791120
J Gen Intern Med. 2017 Aug;32(8):953-954
pubmed: 28284013
An Bras Dermatol. 2011 Mar-Apr;86(2):265-71
pubmed: 21603809
J Crohns Colitis. 2018 May 25;12(6):755-756
pubmed: 29474532
Int J Dermatol. 2009 Sep;48(9):953-5
pubmed: 19702979
J Am Acad Dermatol. 2019 Mar;80(3):781-784
pubmed: 30003991
J Cutan Pathol. 2016 Nov;43(11):946-955
pubmed: 27494987
J Crohns Colitis. 2011 Dec;5(6):633-7
pubmed: 22115387
J Assoc Physicians India. 2019 Apr;67(4):84-85
pubmed: 31309809
Presse Med. 2007 Mar;36(3 Pt 1):419-24
pubmed: 17321363
Orphanet J Rare Dis. 2007 Jul 26;2:34
pubmed: 17655751
Arch Dermatol. 2004 May;140(5):570-4
pubmed: 15148101
Am J Gastroenterol. 1990 Jun;85(6):711-6
pubmed: 2353691
Inflamm Bowel Dis. 2008 Dec;14(12):1757-8
pubmed: 18623176
Int J Dermatol. 2006 Jun;45(6):702-8
pubmed: 16796632
Curr Gastroenterol Rep. 2019 May 16;21(7):31
pubmed: 31098819
Cureus. 2020 Feb 10;12(2):e6928
pubmed: 32190481
J Hand Surg Am. 2001 Jul;26(4):679-85
pubmed: 11466644
Z Rheumatol. 1992 May-Jun;51(3):121-6
pubmed: 1502858
JAMA Dermatol. 2013 May;149(5):592-7
pubmed: 23677084
Clin J Gastroenterol. 2011 Jun;4(3):151-156
pubmed: 26189346
Dermatology. 2015;230(4):293-8
pubmed: 25791317
Front Immunol. 2019 Mar 12;10:414
pubmed: 30930894
Am J Ther. 2019 Sep/Oct;26(5):e616-e617
pubmed: 30074533
J Am Acad Dermatol. 1990 Sep;23(3 Pt 1):503-7
pubmed: 2212153
Rev Clin Esp. 1990 Apr;186(6):264-9
pubmed: 2203115
Acta Dermatovenerol Alp Pannonica Adriat. 2018 Sep;27(3):161-163
pubmed: 30244270
Arch Dermatol. 2006 Jan;142(1):57-63
pubmed: 16415387
Rev Esp Enferm Dig. 2015 Dec;107(12):765-6
pubmed: 26671591
Front Med (Lausanne). 2020 Feb 18;7:20
pubmed: 32133363
Eur J Gastroenterol Hepatol. 1997 Jul;9(7):715-20
pubmed: 9262983
J Clin Gastroenterol. 1996 Jul;23(1):29-34
pubmed: 8835896
Clin Dev Immunol. 2005 Jun;12(2):145-9
pubmed: 16050146
JAMA Ophthalmol. 2013 Jun;131(6):791, 792-3
pubmed: 23764707
J Hand Surg Am. 1983 Sep;8(5 Pt 1):573-5
pubmed: 6630931
Gastroenterology. 1979 Oct;77(4 Pt 2):914-20
pubmed: 467943
J Cutan Pathol. 2012 May;39(5):481-92
pubmed: 22515220
Acta Gastroenterol Belg. 1999 Jul-Sep;62(3):372-4
pubmed: 10547905
J Clin Epidemiol. 2016 Jan;69:199-207.e2
pubmed: 26307459
Hepatogastroenterology. 2004 May-Jun;51(57):768-70
pubmed: 15143912
Br J Dermatol. 1997 Oct;137(4):609-13
pubmed: 9390341
An Bras Dermatol. 2012 May-Jun;87(3):450-5
pubmed: 22714761
J Crohns Colitis. 2015 Jun;9(6):517
pubmed: 25770165
Br J Dermatol. 1992 Jul;127(1):36-8
pubmed: 1637692
Postgrad Med J. 2000 Nov;76(901):713-4
pubmed: 11060149
J Gastroenterol Hepatol. 2015 Jun;30(6):965
pubmed: 25916478
Australas J Dermatol. 2009 Feb;50(1):48-51
pubmed: 19178493
Surv Ophthalmol. 2008 May-Jun;53(3):219-26
pubmed: 18501268
Arch Dermatol. 1999 Jan;135(1):62-6
pubmed: 9923783
Int J Dermatol. 1993 Apr;32(4):261-8
pubmed: 8486457
J Eur Acad Dermatol Venereol. 2019 Oct;33(10):e380-e381
pubmed: 31081562
Clin Exp Rheumatol. 1999 Sep-Oct;17(5):607-10
pubmed: 10544847
BMJ. 1988 Dec 10;297(6662):1513-4
pubmed: 3147051
BMJ Case Rep. 2015 Sep 02;2015:
pubmed: 26336190
Gastroenterology. 2009 May;136(5):1507, 1846
pubmed: 19336217
Ann Intern Med. 2016 Jan 5;164(1):10-22
pubmed: 26641955
BMJ. 2009 Jul 15;339:b2293
pubmed: 19605450
Australas J Dermatol. 2017 Feb;58(1):53-57
pubmed: 26299606
BMJ Case Rep. 2018 Mar 23;2018:
pubmed: 29574433
BMJ Case Rep. 2016 May 11;2016:
pubmed: 27170614
Dig Liver Dis. 2004 May;36(5):361-6
pubmed: 15191207
Z Gastroenterol. 2009 Aug;47(8):753-7
pubmed: 19662588
Acta Gastroenterol Belg. 2005 Jul-Sep;68(3):376-9
pubmed: 16268426
J Crohns Colitis. 2018 Aug 29;12(9):1134-1135
pubmed: 29788419
Br J Dermatol. 2007 Mar;156(3):480-5
pubmed: 17300237
Gastroenterology. 2003 Feb;124(2):287
pubmed: 12557132
Proc (Bayl Univ Med Cent). 2018 Sep 19;31(4):460-461
pubmed: 30948979
Clin Exp Dermatol. 1996 Mar;21(2):175
pubmed: 8759219
Clin Rheumatol. 2015 Nov;34(11):1993-4
pubmed: 26292633
Australas J Dermatol. 1998 May;39(2):116-8
pubmed: 9611384
Pathology. 2013 Feb;45(2):198-200
pubmed: 23277177
J Am Acad Dermatol. 2008 Aug;59(2 Suppl 1):S58-60
pubmed: 18625393
Inflamm Bowel Dis. 2004 May;10(3):207-14
pubmed: 15290913
J Clin Gastroenterol. 1995 Dec;21(4):317-9
pubmed: 8583109
Gastroenterology. 2005 Sep;129(3):827-36
pubmed: 16143122
BMJ Case Rep. 2009;2009:
pubmed: 21687021
JAMA Dermatol. 2016 Jul 1;152(7):842-4
pubmed: 27028556
Dis Colon Rectum. 2001 Oct;44(10):1526-9
pubmed: 11598485
Gastroenterol Clin North Am. 2002 Mar;31(1):307-27
pubmed: 12122740
Pan Afr Med J. 2015 Jun 24;21:151
pubmed: 26327988
Int J Dermatol. 2007 Jun;46(6):571-4
pubmed: 17550553
Br J Dermatol. 2003 Sep;149(3):675-7
pubmed: 14511020
Clin Exp Dermatol. 1995 May;20(3):279-80
pubmed: 7671433
Can J Gastroenterol. 2013 Mar;27(3):124-5
pubmed: 23516674
Am J Gastroenterol. 2001 Apr;96(4):1116-22
pubmed: 11316157
An Bras Dermatol. 2017 Mar-Apr;92(2):263-265
pubmed: 28538894
J Med Case Rep. 2009 Sep 10;3:8997
pubmed: 19918283
Dermatol Online J. 2016 Feb 17;22(2):
pubmed: 27267194
Med Clin (Barc). 1997 Nov 1;109(15):588-91
pubmed: 9441195
J Dermatol. 2013 Apr;40(4):267-71
pubmed: 23294021
World J Gastroenterol. 2011 Jun 14;17(22):2702-7
pubmed: 21734777
J Eur Acad Dermatol Venereol. 2016 Jan;30(1):195-6
pubmed: 25201185
Pract Neurol. 2012 Apr;12(2):126-30
pubmed: 22450461
Med Princ Pract. 2019;28(2):196-198
pubmed: 30376667
Rev Esp Enferm Dig. 2003 Mar;95(3):233-6, 229-32
pubmed: 12760712
Curr Drug Saf. 2015;10(3):266-8
pubmed: 26219289
An Bras Dermatol. 2011 Jul-Aug;86(4):702-7
pubmed: 21987136
BMJ Case Rep. 2017 Mar 15;2017:
pubmed: 28298380
Rom J Morphol Embryol. 2016;57(3):1145-1147
pubmed: 28002536
Br J Dermatol. 1991 Apr;124(4):348-53
pubmed: 2025555
J Am Acad Dermatol. 1994 Oct;31(4):535-56; quiz 557-60
pubmed: 8089280
Acta Derm Venereol. 1989;69(5):444-5
pubmed: 2572117